Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference CallBusiness Wire • 10/11/21
Simulations Plus to Participate in BofA Securities and Oppenheimer Investor ConferencesBusiness Wire • 09/08/21
Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical CompanyBusiness Wire • 08/19/21
Simulations Plus: Growth Speculation, Buy The Dip In This Drug Testing CompanySeeking Alpha • 08/01/21
Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/12/21
Earnings Preview: Simulations Plus (SLP) Q3 Earnings Expected to DeclineZacks Investment Research • 07/05/21
Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference CallBusiness Wire • 06/28/21
Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF)Business Wire • 06/17/21
Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor ConferenceBusiness Wire • 05/27/21
Simulations Plus to Present at 16th Annual Needham Virtual Technology & Media ConferenceBusiness Wire • 05/13/21